Product Added to Cart!
$200.90

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 2-3 weeks for production.
Sku CI05304_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Na-Boc-Nim-benzyl-L-histidine
Brand Name
Chem Impex
Product Number
05304
CAS
20898-44-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
6993429
IUPAC Name
(2S)-3-(1-benzylimidazol-4-yl)-2-(2-methylpropan-2-yl)oxycarbonylaminopropanoic acid
InChI Key
OUHPNBGKEMHUCQ-HNNXBMFYSA-N
SMILES
CC(C)(C)OC(=O)NC@@H(CC1=CN(C=N1)CC2=CC=CC=C2)C(=O)O

Description

Na-Boc-Nim-benzyl-L-histidine is widely utilized in research focused on:

Peptide Synthesis: This compound serves as a key building block in the synthesis of peptides, particularly in the development of biologically active compounds and pharmaceuticals.

Drug Development: Its unique structure allows for modifications that can enhance the efficacy and selectivity of drug candidates, making it valuable in medicinal chemistry.

Bioconjugation: The compound is used in bioconjugation processes, where it helps attach biomolecules to therapeutic agents, improving targeted delivery in cancer therapies.

Research in Enzyme Inhibition: It plays a role in studies aimed at understanding enzyme mechanisms, particularly in the context of designing inhibitors for various diseases.

Protein Engineering: The compound is instrumental in protein engineering applications, providing researchers with tools to modify protein properties for enhanced stability and activity.

References Data Source From Pubchem

Synthesis and Characterization of a Series of Orthogonally Protected l-Carnosine Derivatives

Publication Name: International Journal of Peptide Research and Therapeutics
Publication Date: 2018-02-12
DOI: 10.1007/s10989-018-9680-2

Macroheterocycles. IV. Synthesis and analogesic activity of crown ethers containing leu-enkephalin and thyroliberin groups

Publication Name: Pharmaceutical Chemistry Journal
Publication Date: 1992-05
DOI: 10.1007/bf00772913